A Phase II Trial of BBR 2778 in Combination With Cytarabine, Methylprednisolone and Cisplatin (BSHAP) as Salvage in Patients With Relapsed Aggressive Non-Hodgkin's Lymphoma.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 14 Jul 2009
At a glance
- Drugs Cisplatin; Cytarabine; Methylprednisolone; Pixantrone
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 24 Sep 2005 New trial record.